Axinn Named a “Legal Lion” for Federal Circuit Patent Win
January 18, 2019
Axinn was named a “Legal Lion” in the Law360 Weekly Verdict roundup for its Federal Circuit win on behalf of Alvogen Pine Brook LLC. On January 14, 2019, the Federal Circuit upheld a lower court ruling that cleared Axinn’s client Alvogen of patent infringement. The decision affirmed Axinn’s trial court victory, in which a Delaware Federal District court ruled that Alvogen’s generic version of the colitis medication Uceris® did not infringe a patent owned by Cosmo Technologies Ltd. Alvogen was represented by Axinn partners Jason Murata, who argued the case before the Federal Circuit, and Matthew Becker, who tried the case before the Delaware District Court.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
GCR Live: Law Leaders Europe 2025
Speaking Engagement
Antitrust
AHLA Annual Meeting 2025
Speaking Engagement
Antitrust
SABA North America Annual Conference 2025
Speaking Engagement
Antitrust
Navigating Compliance: How the 2025 Hart-Scott-Rodino Updates Are Impacting Businesses
Webinar
Antitrust
Volunteer Lawyers for the Arts – Champions of the Arts Awards and Gala 2025
Sponsorship
Antitrust
NJSBA Annual Meeting and Convention 2025
Speaking Engagement
Intellectual Property
Cost-Effective and Efficient IP Litigation Strategies – Making Paragraph IV Litigation Work for You
Webinar
Intellectual Property
Hartford HealthCare Black and Red Gala 2025
Sponsorship
Antitrust
Informa CompLaw Antitrust West Coast Conference 2025
Speaking Engagement
Antitrust
Recent Decision Shows the Heavy Burden of Actual Malice in Defamation Suits
Axinn Viewpoints
Litigation & Trials